Since 2014, Master Courses have complemented the programmes of World Cancer Congresses addressing a range of cancer, as well as organisational, topics, supporting the continuing education of more than 700 cancer control professionals over the years.
Purpose-built by internationally recognised leaders in their field, Master Courses combine an online learning component in the three months prior to Congress, with a face-to-face workshop, in a unique blend of modular learning and peer-exchange.
Master Courses are offered free of charge to Congress delegates. Applications will open in late March through the Congress registration platform.
MASTER COURSE TOPICS
In 2020 Congress delegates will be able to choose from an offer of six Master Courses, covering a diverse range of topics. Check out the confirmed topics below.
1. Leadership strategies: Achieve your leadership potential
Overview: This course will provide the tools and case-based discussions for participants to increase personal leadership competencies with a focus around communication, collaboration and performance. By addressing traits and processes such as emotional intelligence, behavioural styles, coaching, performance review and goal setting, the course will impart learning applicable to multiple circumstances, and will help participants to support their personal leadership style while fostering their organisation’s success.
Target Audience: Anyone with a personal interest in leadership and increasing their self-awareness and understanding of others. Participants do not need to currently be serving in a leadership position, but some leadership experience, either personal or professional, is recommended.
Course leader: Lotte Mulder, Director of Leadership and Empowerment, American Society for Clinical Pathology (ASCP)
2. Practical aspects for the integration of radiotherapy services in national cancer programmes
Overview: The aim of this course is to broaden the knowledge of cancer control professionals about the need for radiotherapy as an integral part of cancer care. The course will cover the key steps in and considerations for developing radiotherapy as part of a national cancer programme, from identifying the needs and planning service availability and access, to addressing the human resources and cost implications.
Target Audience: The course is aimed at non-radiotherapy professionals. Cancer advocates and policy-makers wishing to make the case for implementing or upgrading radiotherapy services in their localities, will find this course particularly useful.
Course leader: Eduardo Zubizarreta, Head Applied Radiation Biology and Radiotherapy Section, International Atomic Energy Agency (IAEA)
3. Access to essential cancer medicines
Overview: The purpose of this course is to review the landscape and challenges of essential cancer medicine access, especially in developing countries, and delve into a methodology for evaluating medicine availability and approaches to mitigating drug stock-outs. The course will take a holistic evaluation of cancer medicine access, including factors unrelated to price, and will focus on potential solutions to mitigating the various challenges around access.
Target Audience: Providers who prescribe and administer chemotherapy, agencies involved in formulation, procurement and supply of national essential medicines for cancer treatment and advocates promoting better access in developing countries.
Course leaders: Yehoda Martei, Assistant Professor of Medicine, University of Pennsylvania and Shalini Jayasekar-Zürn, Senior Advocacy Manager, Union for International Cancer Control (UICC)
4. Multisectoral approaches to increase patient engagement for better cancer control
Overview: This course will draw on practical examples and approaches from across sectors to outline how the engagement of patients in decision-making processes along the cancer control continuum leads to better quality in cancer care. Participants will access latest findings, strategies and tools to reinforce patient engagement as well as testimonies from patients, survivors and caregivers themselves to explain how to best ensure patient-centred systems and increase the quality of cancer care in various settings.
Target Audience: Representatives of patient support groups, survivors and caregivers willing to engage personally in representing the patient / caregiver perspective. Cancer societies and other cancer NGOs managing patient support groups as part of their mission. Other stakeholders interested in further the engagement of patients, including the pharmaceutical industry, NGOs, international organisations, academics, researchers, key opinion leaders, policy-makers, regulators and healthcare professionals.
Course leader: Mélanie Samson, Senior Manager Capacity Building, Union for International Cancer Control (UICC)
5. Essential elements for Comprehensive Cancer Centres – A framework for integration of care, research, education and innovation
Overview: This course will introduce a framework for comprehensive cancer centres as a nucleus of cancer care delivery. Participants will explore how these centres should serve as a hubs for education, research, and clinical care and are integrated within health systems. Among others, this course will focus on the concepts of structured decision-making, multidisciplinary care delivery, quality systems and accreditation. Participants will gain a systems-level perspective on the fundamental resources and structures needed for the development of comprehensive cancer centres grounded in real-world case studies from India, Canada, Jordan and Brazil.
Target Audience: Cancer clinicians, administrators, researchers, professionals from non-governmental organisations, and advocates engaged in developing, scaling up or advocating for comprehensive cancer services and centres. The course is applicable to individuals working within low-, middle- and high- income settings.
Course leaders: Meredith Giuliani, Medical Director Cancer Education, Princess Margaret Cancer Centre and Mary Gospodarowicz, Medical Director, Princess Margaret Cancer Centre
6. Tobacco taxation: Strategies to expand the single most effective tobacco control policy
Overview: This course will explore the importance of why cancer organisations must include tobacco taxation in their mission as a key strategic intervention to reduce smoking-related cancers, and will help participants build a strategy that they can include in their day-to-day work. While we know tobacco taxation – one of the WHO’s best-buys on Non-Communicable diseases - to be a hugely impactful intervention that can save millions of lives, it is sadly still also one of the most underused. This course seeks to reverse this trend and support cancer organisations to understand the tobacco taxation situation in their country, engage the appropriate country-level stakeholders and equip them with tools to counter frequent arguments against tax increases.
Target Audience: This course is aimed at senior staff with decision-making authority in cancer organisations in low- and middle-income countries who interact (or would like to) with government / decision-makers as part of their work.
Course leaders: Jacqui Drope, Managing Director Global Cancer Prevention and Early Detection, American Cancer Society and Bekki Field, Senior Programme Lead International Cancer Prevention, Cancer Research UK
Master Courses 2020 Timeline
March 2020: Announcement of Master Courses
March - April 2020: Applications timeline
May 2020: selection of participants
June – September 2020: Master Courses’ online component
19 Oct 2020: Master Courses' on-site workshops
Master Course supporter(s)
Master Courses are supported by The American Society for Clinical Pathology (ASCP).
More sponsors to come...
For any assistance or more information around the 2020 WCC Master Courses, please contact the Education team.